American Century Companies’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
ACA
DTC
BI
DCM
American Century Companies's GPCR Position: Q1 2026 in Review
American Century Companies increased its Structure Therapeutics (GPCR) stake by 184% in Q1 2026, buying an estimated $63.7M and bringing the position to 1,438,031 shares worth $69.3M. The position accounts for 0.04% of the portfolio, ranked #605.
American Century Companies first reported a position in GPCR in Q1 2024 and has held it in 9 quarters since. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.
- American Century Companies held 1,438,031 shares of Structure Therapeutics worth $69.3M as of Q1 2026.
- American Century Companies bought 931,072 Structure Therapeutics shares in Q1 2026, an estimated $63.7M.
- Structure Therapeutics made up 0.04% of American Century Companies's portfolio in Q1 2026, its #605 holding.
- American Century Companies first reported a position in Structure Therapeutics in Q1 2024 and has held it in 9 quarters since.
- 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.